Cumulus Oncology secures £9 million funding

Eos Advisory and the Scottish National Investment Bank behind cancer therapeutics firm’s latest round.

Cancer therapeutics company Cumulus Oncology has secured a £9m funding package.

The Edinburgh-based business creates spin-out companies involved in the development of groundbreaking new cancer treatments.

It plans to use the money, which includes £6m from the Scottish National Investment Bank, to expand its portfolio of companies and help accelerate the way new cancer drugs are progressed from discovery, through clinical trials to patients.

Read more HERE.